Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November 2013 Volume 8 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November 2013 Volume 8 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review

Crosstalk between dopamine receptors and the Na+/K+‑ATPase (Review)

  • Authors:
    • Li‑Nan Zhang
    • Jun‑Xia Li
    • Liang Hao
    • Yong‑Jun Sun
    • Ying‑Hua Xie
    • Shao‑Mei Wu
    • Lei Liu
    • Xiao-Long Chen
    • Zi-Bin Gao
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacy, College of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, Hebei 050018, P.R. China, Department of Pharmacology, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China, Department of Neurosurgery, Third Hospital of Shijiazhuang, Shijiazhuang, Hebei 050011, P.R. China
  • Pages: 1291-1299
    |
    Published online on: September 19, 2013
       https://doi.org/10.3892/mmr.2013.1697
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Dopamine (DA) receptors, which belong to the G protein‑coupled receptor family, are the target of ~50% of all modern medicinal drugs and constitute a large and diverse class of proteins whose primary function is to transduce extracellular stimuli into intracellular signals. Na+/K+‑ATPase (NKA) is ubiquitous and crucial for the maintenance of intracellular ion homeostasis and excitability. Furthermore, it plays a critical role in diverse effects, including clinical cardiotonic and cardioprotective effects, ischemic preconditioning in the brain, natriuresis, lung edema clearance and other processes. NKA regulation is of physiological and pharmacological importance and has species‑ and tissue‑specific variations. The activation of DA receptors regulates NKA expression/activity and trafficking in various tissues and cells, for example in the kidney, lung, intestine, brain, non‑pigmented ciliary epithelium and the vascular bed. DA receptor‑mediated regulation of NKA mediates a diverse range of cellular responses and includes endocytosis/exocytosis, phosphorylation/dephosphorylation of the α subunit of NKA and multiple signaling pathways, including phosphatidylinositol (PI)‑phospholipase C/protein kinase (PK) C, cAMP/PKA, PI3K, adaptor protein 2, tyrosine phosphatase and mitogen‑activated protein kinase/extracellular signal‑regulated protein kinase. Furthermore, in brain and HEK293T cells, D1 and D2 receptors exist in a complex with NKA. Among D1 and D2 receptors and NKA, regulations are reciprocal, which leads to crosstalk between DA receptors and NKA. In the present study, the current understanding of signaling mechanisms responsible for the crosstalk between DA receptors and NKA, as well as with specific consequent functions, is reviewed.
View Figures

Figure 1

View References

1 

Contreras F, Fouillioux C, Bolivar A, et al: Dopamine, hypertension and obesity. J Hum Hypertens. 16(Suppl 1): S13–S17. 2002. View Article : Google Scholar

2 

Skou JC: The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim Biophys Acta. 23:394–401. 1957. View Article : Google Scholar : PubMed/NCBI

3 

Wright EM, Hirayama BA and Loo DF: Active sugar transport in health and disease. J Intern Med. 261:32–43. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Namekata K, Harada C, Kohyama K, Matsumoto Y and Harada T: Interleukin-1 stimulates glutamate uptake in glial cells by accelerating membrane trafficking of Na+/K+-ATPase via actin depolymerization. Mol Cell Biol. 28:3273–3280. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Swift F, Birkeland JA, Tovsrud N, et al: Altered Na+/Ca2+-exchanger activity due to downregulation of Na+/K+-ATPase alpha2-isoform in heart failure. Cardiovasc Res. 78:71–78. 2008.PubMed/NCBI

6 

Blanco G, DeTomaso AW, Koster J, Xie ZJ and Mercer RW: The alpha-subunit of the Na, K-ATPase has catalytic activity independent of the beta-subunit. J Biol Chem. 269:23420–23425. 1994.PubMed/NCBI

7 

Jaisser F, Jaunin P, Geering K, Rossier BC and Horisberger JD: Modulation of the Na, K-pump function by beta subunit isoforms. J Gen Physiol. 103:605–623. 1994. View Article : Google Scholar : PubMed/NCBI

8 

Beguin P, Wang X, Firsov D, et al: The gamma subunit is a specific component of the Na, K-ATPase and modulates its transport function. EMBO J. 16:4250–4260. 1997. View Article : Google Scholar : PubMed/NCBI

9 

Shamraj OI and Lingrel JB: A putative fourth Na+, K(+)-ATPase alpha-subunit gene is expressed in testis. Proc Natl Acad Sci USA. 91:12952–12956. 1994.PubMed/NCBI

10 

Barcroft LC, Moseley AE, Lingrel JB and Watson AJ: Deletion of the Na/K-ATPase alpha1-subunit gene (Atp1a1) does not prevent cavitation of the preimplantation mouse embryo. Mech Dev. 121:417–426. 2004.PubMed/NCBI

11 

James PF, Grupp IL, Grupp G, et al: Identification of a specific role for the Na, K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell. 3:555–563. 1999. View Article : Google Scholar : PubMed/NCBI

12 

Ikeda K, Onimaru H, Yamada J, et al: Malfunction of respiratory-related neuronal activity in Na+, K+-ATPase alpha2 subunit-deficient mice is attributable to abnormal Cl− homeostasis in brainstem neurons. J Neurosci. 24:10693–10701. 2004.PubMed/NCBI

13 

Dostanic I, Paul RJ, Lorenz JN, Theriault S, Van Huysse JW and Lingrel JB: The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol. 288:H477–H485. 2005. View Article : Google Scholar

14 

Dostanic I, Lorenz JN, Schultz Jel J, et al: The alpha2 isoform of Na, K-ATPase mediates ouabain-induced cardiac inotropy in mice. J Biol Chem. 278:53026–53034. 2003. View Article : Google Scholar : PubMed/NCBI

15 

Dostanic I, Schultz Jel J, Lorenz JN and Lingrel JB: The alpha 1 isoform of Na, K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heart. J Biol Chem. 279:54053–54061. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Pierre SV, Yang C, Yuan Z, et al: Ouabain triggers preconditioning through activation of the Na+, K+-ATPase signaling cascade in rat hearts. Cardiovasc Res. 73:488–496. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Blair JE, Macarie C, Ruzyllo W, et al; HORIZON-HF investigators. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am J Ther. 15:231–240. 2008. View Article : Google Scholar

18 

Tian D, Dmitrieva RI, Doris PA, et al: Protein kinase M zeta regulation of Na/K ATPase: a persistent neuroprotective mechanism of ischemic preconditioning in hippocampal slice cultures. Brain Res. 1213:127–139. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Zhang L, Zhang Z, Guo H and Wang Y: Na+/K+-ATPase-mediated signal transduction and Na+/K+-ATPase regulation. Fundam Clin Pharmacol. 22:615–621. 2008.

20 

Hazelwood LA, Free RB, Cabrera DM, Skinbjerg M and Sibley DR: Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+, K+-ATPase. J Biol Chem. 283:36441–36453. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Carey RM: Theodore Cooper Lecture: Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension. 38:297–302. 2001. View Article : Google Scholar

22 

Jose PA, Eisner GM and Felder RA: Regulation of blood pressure by dopamine receptors. Nephron Physiol. 95:p19–p27. 2003. View Article : Google Scholar : PubMed/NCBI

23 

Jose PA, Eisner GM and Felder RA: Renal dopamine and sodium homeostasis. Curr Hypertens Rep. 2:174–183. 2000. View Article : Google Scholar

24 

Felder RA, Felder CC, Eisner GM and Jose PA: The dopamine receptor in adult and maturing kidney. Am J Physiol. 257:F315–F327. 1989.PubMed/NCBI

25 

Chibalin AV, Ogimoto G, Pedemonte CH, et al: Dopamine- induced endocytosis of Na+, K+-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and is responsible for the decreased activity in epithelial cells. J Biol Chem. 274:1920–1927. 1999.PubMed/NCBI

26 

Chibalin AV, Pedemonte CH, Katz AI, Feraille E, Berggren PO and Bertorello AM: Phosphorylation of the catalyic alpha-subunit constitutes a triggering signal for Na+, K+-ATPase endocytosis. J Biol Chem. 273:8814–8819. 1998. View Article : Google Scholar : PubMed/NCBI

27 

Chibalin AV, Zierath JR, Katz AI, Berggren PO and Bertorello AM: Phosphatidylinositol 3-kinase-mediated endocytosis of renal Na+, K+-ATPase alpha subunit in response to dopamine. Mol Biol Cell. 9:1209–1220. 1998. View Article : Google Scholar : PubMed/NCBI

28 

Chen Z, Krmar RT, Dada L, et al: Phosphorylation of adaptor protein-2 mu2 is essential for Na+, K+-ATPase endocytosis in response to either G protein-coupled receptor or reactive oxygen species. Am J Respir Cell Mol Biol. 35:127–132. 2006.PubMed/NCBI

29 

Ogimoto G, Yudowski GA, Barker CJ, et al: G protein-coupled receptors regulate Na+, K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin. Proc Natl Acad Sci USA. 97:3242–3247. 2000.PubMed/NCBI

30 

Done SC, Leibiger IB, Efendiev R, et al: Tyrosine 537 within the Na+, K+-ATPase alpha-subunit is essential for AP-2 binding and clathrin-dependent endocytosis. J Biol Chem. 277:17108–17111. 2002.PubMed/NCBI

31 

Yudowski GA, Efendiev R, Pedemonte CH, Katz AI, Berggren PO and Bertorello AM: Phosphoinositide-3 kinase binds to a proline- rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking. Proc Natl Acad Sci USA. 97:6556–6561. 2000. View Article : Google Scholar : PubMed/NCBI

32 

Chibalin AV, Katz AI, Berggren PO and Bertorello AM: Receptor-mediated inhibition of renal Na(+)-K(+)-ATPase is associated with endocytosis of its alpha- and beta-subunits. Am J Physiol. 273:C1458–C1465. 1997.

33 

Khundmiri SJ and Lederer E: PTH and DA regulate Na-K ATPase through divergent pathways. Am J Physiol Renal Physiol. 282:F512–F522. 2002. View Article : Google Scholar : PubMed/NCBI

34 

Gomes P and Soares-Da-Silva P: D2-like receptor-mediated inhibition of Na+-K+-ATPase activity is dependent on the opening of K+ channels. Am J Physiol Renal Physiol. 283:F114–F123. 2002.PubMed/NCBI

35 

Salyer S, Lesousky N, Weinman EJ, Clark BJ, Lederer ED and Khundmiri SJ: Dopamine regulation of Na+-K+-ATPase requires the PDZ-2 domain of sodium hydrogen regulatory factor-1 (NHERF-1) in opossum kidney cells. Am J Physiol Cell Physiol. 300:C425–C434. 2011.PubMed/NCBI

36 

Zhang YR and Yuan ZY: Dopamine-mediated inhibition of renal Na+/K+-ATPase in HK-2 cells is reduced by ouabain. Clin Exp Pharmacol Physiol. 37:613–618. 2010. View Article : Google Scholar : PubMed/NCBI

37 

Gildea JJ, Israel JA, Johnson AK, Zhang J, Jose PA and Felder RA: Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension. 54:1070–1076. 2009. View Article : Google Scholar : PubMed/NCBI

38 

Gildea JJ, Shah I, Weiss R, et al: HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling. Hypertension. 56:505–511. 2010. View Article : Google Scholar

39 

Bertorello A and Aperia A: Inhibition of proximal tubule Na(+)-K(+)-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol. 259:F924–F928. 1990.

40 

Felder CC, Campbell T, Albrecht F and Jose PA: Dopamine inhibits Na(+)-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol. 259:F297–F303. 1990.

41 

Banday AA and Lokhandwala MF: Oxidative stress reduces renal dopamine D1 receptor-Gq/11alpha G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2. Am J Physiol Renal Physiol. 293:F306–F315. 2007.PubMed/NCBI

42 

Shahedi M, Laborde K, Bussieres L, Dechaux M and Sachs C: Protein kinase C activation causes inhibition of Na/K-ATPase activity in Madin-Darby canine kidney epithelial (MDCK) cells. Pflugers Arch. 420:269–274. 1992. View Article : Google Scholar

43 

Nishi A, Eklof AC, Bertorello AM and Aperia A: Dopamine regulation of renal Na+, K(+)-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension. 21:767–771. 1993.

44 

Banday AA, Lau YS and Lokhandwala MF: Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension. 51:367–375. 2008. View Article : Google Scholar

45 

Gomes P and Soares-da-Silva P: Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na(+)-K(+)-ATPase activity. Am J Physiol Renal Physiol. 282:F1084–F1096. 2002.PubMed/NCBI

46 

Gomes P and Soares-da-Silva P: Dopamine-induced inhibition of Na+-K+-ATPase activity requires integrity of actin cytoskeleton in opossum kidney cells. Acta Physiol Scand. 175:93–101. 2002.

47 

Efendiev R, Bertorello AM and Pedemonte CH: PKC-beta and PKC-zeta mediate opposing effects on proximal tubule Na+, K+-ATPase activity. FEBS Lett. 456:45–48. 1999. View Article : Google Scholar : PubMed/NCBI

48 

Huang H, Ren H, Chen C, et al: D3 dopamine receptor regulation of D5 receptor expression and function in renal proximal tubule cells. Hypertens Res. 35:639–647. 2012.

49 

Tsuchida H, Imai G, Shima Y, Satoh T and Owada S: Mechanism of sodium load-induced hypertension in non-insulin dependent diabetes mellitus model rats: defective dopaminergic system to inhibit Na-K-ATPase activity in renal epithelial cells. Hypertens Res. 24:127–135. 2001. View Article : Google Scholar

50 

Aperia A: 2011 Homer Smith Award: To serve and protect: classic and novel roles for Na+, K+-adenosine triphosphatase. J Am Soc Nephrol. 23:1283–1290. 2012. View Article : Google Scholar : PubMed/NCBI

51 

Lecuona E, Garcia A and Sznajder JI: A novel role for protein phosphatase 2A in the dopaminergic regulation of Na, K-ATPase. FEBS Lett. 481:217–220. 2000. View Article : Google Scholar : PubMed/NCBI

52 

Lecuona E, Dada LA, Sun H, et al: Na, K-ATPase alpha1-subunit dephosphorylation by protein phosphatase 2A is necessary for its recruitment to the plasma membrane. FASEB J. 20:2618–2620. 2006. View Article : Google Scholar : PubMed/NCBI

53 

Helms MN, Chen XJ, Ramosevac S, Eaton DC and Jain L: Dopamine regulation of amiloride-sensitive sodium channels in lung cells. Am J Physiol Lung Cell Mol Physiol. 290:L710–L722. 2006. View Article : Google Scholar : PubMed/NCBI

54 

Adir Y, Azzam ZS, Lecuona E, et al: Augmentation of endogenous dopamine production increases lung liquid clearance. Am J Respir Crit Care Med. 169:757–763. 2004. View Article : Google Scholar : PubMed/NCBI

55 

Olivera WG, Ridge KM and Sznajder JI: Lung liquid clearance and Na, K-ATPase during acute hyperoxia and recovery in rats. Am J Respir Crit Care Med. 152:1229–1234. 1995. View Article : Google Scholar : PubMed/NCBI

56 

Saldias FJ, Lecuona E, Comellas AP, Ridge KM and Sznajder JI: Dopamine restores lung ability to clear edema in rats exposed to hyperoxia. Am J Respir Crit Care Med. 159:626–633. 1999. View Article : Google Scholar : PubMed/NCBI

57 

Jaitovich A and Sznajder JI: Improving survival by increasing lung edema clearance: is airspace delivery of dopamine a solution? Crit Care. 12:1352008. View Article : Google Scholar : PubMed/NCBI

58 

Azzam ZS, Dumasius V, Saldias FJ, Adir Y, Sznajder JI and Factor P: Na, K-ATPase overexpression improves alveolar fluid clearance in a rat model of elevated left atrial pressure. Circulation. 105:497–501. 2002. View Article : Google Scholar : PubMed/NCBI

59 

Ridge KM, Dada L, Lecuona E, et al: Dopamine-induced exocytosis of Na, K-ATPase is dependent on activation of protein kinase C-epsilon and -delta. Mol Biol Cell. 13:1381–1389. 2002. View Article : Google Scholar : PubMed/NCBI

60 

Guerrero C, Lecuona E, Pesce L, Ridge KM and Sznajder JI: Dopamine regulates Na-K-ATPase in alveolar epithelial cells via MAPK-ERK-dependent mechanisms. Am J Physiol Lung Cell Mol Physiol. 281:L79–L85. 2001.PubMed/NCBI

61 

Guerrero C, Pesce L, Lecuona E, Ridge KM and Sznajder JI: Dopamine activates ERKs in alveolar epithelial cells via Ras-PKC-dependent and Grb2/Sos-independent mechanisms. Am J Physiol Lung Cell Mol Physiol. 282:L1099–L1107. 2002. View Article : Google Scholar : PubMed/NCBI

62 

Vieira-Coelho MA, Teixeira VA, Finkel Y, Soares-Da-Silva P and Bertorello AM: Dopamine-dependent inhibition of jejunal Na+-K+-ATPase during high-salt diet in young but not in adult rats. Am J Physiol. 275:G1317–G1323. 1998.PubMed/NCBI

63 

Lucas-Teixeira VA, Hussain T, Serrao P, Soares-da-Silva P and Lokhandwala MF: Intestinal dopaminergic activity in obese and lean Zucker rats: response to high salt intake. Clin Exp Hypertens. 24:383–396. 2002. View Article : Google Scholar : PubMed/NCBI

64 

Vieira-Coelho MA, Serrao P, Hussain T, Lokhandwala MF and Soares-da-Silva P: Salt intake and intestinal dopaminergic activity in adult and old Fischer 344 rats. Life Sci. 69:1957–1968. 2001. View Article : Google Scholar : PubMed/NCBI

65 

Lucas-Teixeira V, Vieira-Coelho MA and Soares-Da-Silva P: Food intake abolishes the response of rat jejunal Na(+), K(+)-ATPase to dopamine. J Nutr. 130:877–881. 2000.PubMed/NCBI

66 

Vieira-Coelho MA and Soares-da-Silva P: Ontogenic aspects of D1 receptor coupling to G proteins and regulation of rat jejunal Na+, K+ ATPase activity and electrolyte transport. Br J Pharmacol. 129:573–581. 2000.

67 

Vieira-Coelho MA, Serrao P, Guimaraes JT, Pestana M and Soares-da-Silva P: Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney. Am J Physiol Renal Physiol. 279:F1033–F1044. 2000.PubMed/NCBI

68 

Sampaio-Maia B, Serrao P, Moura M and Pestana M: Jejunal dopamine and Na, K-ATPase activity in early chronic renal insufficiency. Nephrology (Carlton). 11:63–67. 2006. View Article : Google Scholar : PubMed/NCBI

69 

Blom H, Ronnlund D, Scott L, et al: Nearest neighbor analysis of dopamine D1 receptors and Na(+)-K(+)-ATPases in dendritic spines dissected by STED microscopy. Microsc Res Tech. 75:220–228. 2012.

70 

Bertorello AM, Hopfield JF, Aperia A and Greengard P: Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature. 347:386–388. 1990.

71 

Pinto Ferreira M, DeLucia R, Luiz Aizenstein M, Glezer I and Scavone C: Fencamfamine modulates sodium, potassium-ATPase through cyclic AMP and cyclic AMP-dependent protein kinase in rat striatum. J Neural Transm. 105:549–560. 1998.PubMed/NCBI

72 

Bagh MB, Maiti AK, Jana S, Banerjee K, Roy A and Chakrabarti S: Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson’s disease. Free Radic Res. 42:574–581. 2008. View Article : Google Scholar : PubMed/NCBI

73 

Yang ZJ, Torbey M, Li X, et al: Dopamine receptor modulation of hypoxic-ischemic neuronal injury in striatum of newborn piglets. J Cereb Blood Flow Metab. 27:1339–1351. 2007. View Article : Google Scholar : PubMed/NCBI

74 

Park WS, Chang YS, Shim JW, et al: Effects of dopamine infusion on cerebral blood flow, brain cell membrane function and energy metabolism in experimental Escherichia coli meningitis in the newborn piglet. J Korean Med Sci. 18:869–875. 2003. View Article : Google Scholar : PubMed/NCBI

75 

Zaitseva T, Shen J, Schears G, Creed J, Wilson DF and Pastuszko A: Effect of catecholamines on activity of Na(+), K(+)-ATPase in neonatal piglet brain during posthypoxic reoxygenation. Comp Biochem Physiol A Mol Integr Physiol. 132:139–145. 2002.

76 

Wu ZQ, Chen J, Chi ZQ and Liu JG: Involvement of dopamine system in regulation of Na+, K+-ATPase in the striatum upon activation of opioid receptors by morphine. Mol Pharmacol. 71:519–530. 2007.PubMed/NCBI

77 

Nakai Y, Dean WL, Hou Y and Delamere NA: Genistein inhibits the regulation of active sodium-potassium transport by dopaminergic agonists in nonpigmented ciliary epithelium. Invest Ophthalmol Vis Sci. 40:1460–1466. 1999.

78 

Rashed SM and Songu-Mize E: Regulation of Na(+)-pump activity by dopamine in rat tail arteries. Eur J Pharmacol. 284:289–297. 1995.

79 

Rashed SM and Songu-Mize E: Regulation of Na+, K(+)-ATPase activity by dopamine in cultured rat aortic smooth muscle cells. Eur J Pharmacol. 305:223–230. 1996.

80 

Cinelli AR, Efendiev R and Pedemonte CH: Trafficking of Na-K-ATPase and dopamine receptor molecules induced by changes in intracellular sodium concentration of renal epithelial cells. Am J Physiol Renal Physiol. 295:F1117–F1125. 2008. View Article : Google Scholar

81 

Steffens M and Feuerstein TJ: Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex - involvement of Na(+)/K(+)-ATPase. Neurochem Int. 44:529–538. 2004.PubMed/NCBI

82 

Kirchheimer C, Mendez CF, Acquier A and Nowicki S: Role of 20-HETE in D1/D2 dopamine receptor synergism resulting in the inhibition of Na+-K+-ATPase activity in the proximal tubule. Am J Physiol Renal Physiol. 292:F1435–F1442. 2007.PubMed/NCBI

83 

Citarella MR, Choi MR, Gironacci MM, Medici C, Correa AH and Fernandez BE: Urodilatin and dopamine: a new interaction in the kidney. Regul Pept. 153:19–24. 2009. View Article : Google Scholar : PubMed/NCBI

84 

Schoffelmeer AN, Vanderschuren LJ, De Vries TJ, Hogenboom F, Wardeh G and Mulder AH: Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons. J Neurosci. 20:3496–3503. 2000.PubMed/NCBI

85 

Zhang Y, Fu C, Ren H, et al: Impaired stimulatory effect of ETB receptor on D(3) receptor in immortalized renal proximal tubule cells of spontaneously hypertensive rats. Kidney Blood Press Res. 34:75–82. 2011. View Article : Google Scholar : PubMed/NCBI

86 

Yu C, Yang Z, Ren H, et al: D3 dopamine receptor regulation of ETB receptors in renal proximal tubule cells from WKY and SHRs. Am J Hypertens. 22:877–883. 2009.

87 

Yang J, Cui Z, He D, et al: Insulin increases D5 dopamine receptor expression and function in renal proximal tubule cells from Wistar-Kyoto rats. Am J Hypertens. 22:770–776. 2009.

88 

Soares-da-Silva P, Pinto-do OP and Bertorello AM: Antagonistic actions of renal dopamine and 5-hydroxytryptamine: increase in Na+, K(+)-ATPase activity in renal proximal tubules via activation of 5-HT1A receptors. Br J Pharmacol. 117:1199–1203. 1996. View Article : Google Scholar : PubMed/NCBI

89 

Khan F, Spicarova Z, Zelenin S, Holtback U, Scott L and Aperia A: Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol. 295:F1110–F1116. 2008. View Article : Google Scholar : PubMed/NCBI

90 

Choi MR, Medici C, Gironacci MM, Correa AH and Fernandez BE: Angiotensin II regulation of renal dopamine uptake and Na(+), K(+)-ATPase activity. Nephron Physiol. 111:p53–p58. 2009.PubMed/NCBI

91 

Aperia A, Holtback U, Syren ML, Svensson LB, Fryckstedt J and Greengard P: Activation/deactivation of renal Na+, K(+)-ATPase: a final common pathway for regulation of natriuresis. FASEB J. 8:436–439. 1994.PubMed/NCBI

92 

Banday AA, Fazili FR and Lokhandwala MF: Insulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C. Am J Physiol Renal Physiol. 293:F877–F884. 2007.PubMed/NCBI

93 

Banday AA, Asghar M, Hussain T and Lokhandwala MF: Dopamine-mediated inhibition of renal Na, K-ATPase is reduced by insulin. Hypertension. 41:1353–1358. 2003. View Article : Google Scholar : PubMed/NCBI

94 

Correa AH, Choi MR, Gironacci M, Aprile F and Fernandez BE: Atrial natriuretic factor decreases renal dopamine turnover and catabolism without modifying its release. Regul Pept. 146:238–242. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang LN, Li JX, Hao L, Sun YJ, Xie YH, Wu SM, Liu L, Chen X and Gao Z: Crosstalk between dopamine receptors and the Na+/K+‑ATPase (Review). Mol Med Rep 8: 1291-1299, 2013.
APA
Zhang, L., Li, J., Hao, L., Sun, Y., Xie, Y., Wu, S. ... Gao, Z. (2013). Crosstalk between dopamine receptors and the Na+/K+‑ATPase (Review). Molecular Medicine Reports, 8, 1291-1299. https://doi.org/10.3892/mmr.2013.1697
MLA
Zhang, L., Li, J., Hao, L., Sun, Y., Xie, Y., Wu, S., Liu, L., Chen, X., Gao, Z."Crosstalk between dopamine receptors and the Na+/K+‑ATPase (Review)". Molecular Medicine Reports 8.5 (2013): 1291-1299.
Chicago
Zhang, L., Li, J., Hao, L., Sun, Y., Xie, Y., Wu, S., Liu, L., Chen, X., Gao, Z."Crosstalk between dopamine receptors and the Na+/K+‑ATPase (Review)". Molecular Medicine Reports 8, no. 5 (2013): 1291-1299. https://doi.org/10.3892/mmr.2013.1697
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang LN, Li JX, Hao L, Sun YJ, Xie YH, Wu SM, Liu L, Chen X and Gao Z: Crosstalk between dopamine receptors and the Na+/K+‑ATPase (Review). Mol Med Rep 8: 1291-1299, 2013.
APA
Zhang, L., Li, J., Hao, L., Sun, Y., Xie, Y., Wu, S. ... Gao, Z. (2013). Crosstalk between dopamine receptors and the Na+/K+‑ATPase (Review). Molecular Medicine Reports, 8, 1291-1299. https://doi.org/10.3892/mmr.2013.1697
MLA
Zhang, L., Li, J., Hao, L., Sun, Y., Xie, Y., Wu, S., Liu, L., Chen, X., Gao, Z."Crosstalk between dopamine receptors and the Na+/K+‑ATPase (Review)". Molecular Medicine Reports 8.5 (2013): 1291-1299.
Chicago
Zhang, L., Li, J., Hao, L., Sun, Y., Xie, Y., Wu, S., Liu, L., Chen, X., Gao, Z."Crosstalk between dopamine receptors and the Na+/K+‑ATPase (Review)". Molecular Medicine Reports 8, no. 5 (2013): 1291-1299. https://doi.org/10.3892/mmr.2013.1697
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team